Shoulder Innovations, Inc. (SI) Financials

Shoulder Innovations, Inc. (SI) reported diluted earnings per share of -$4.65 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Shoulder Innovations, Inc. (SI) had EBITDA of -$23.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Shoulder Innovations, Inc. (SI) had $26.9M in cash and equivalents against $14.9M in long-term debt.

Shoulder Innovations, Inc. (SI) had a gross margin of 76.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Shoulder Innovations, Inc. (SI) had an operating margin of -55.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Shoulder Innovations, Inc. (SI) had a net profit margin of -85.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Shoulder Innovations, Inc. (SI) has a return on equity of -28.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Shoulder Innovations, Inc. (SI) recorded an outflow of $36.0M in free cash flow during fiscal year 2025. This represents a -98.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Shoulder Innovations, Inc. (SI) recorded an outflow of $28.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Shoulder Innovations, Inc. (SI) had $169.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Shoulder Innovations, Inc. (SI) invested $7.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Shoulder Innovations, Inc. (SI) invested $7.7M in research and development during fiscal year 2025.

Shoulder Innovations, Inc. (SI) had 21M shares outstanding as of fiscal year 2025.

Shoulder Innovations, Inc. (SI) had a current ratio of 11.07 as of fiscal year 2025, which is generally considered healthy.

Shoulder Innovations, Inc. (SI) had a debt-to-equity ratio of 0.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Shoulder Innovations, Inc. (SI) had a return on assets of -23.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Shoulder Innovations, Inc. (SI) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $376.6M as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Shoulder Innovations, Inc. (SI) trades at 6.3x sales, its market capitalization divided by revenue of $60.1M revenue, trailing 12 months to June 30, 2026. The market capitalization is $376.6M as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Shoulder Innovations, Inc. (SI) held $124.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $28.6M over that year. Dividing the one by the other, the reported balance equals about 52 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Shoulder Innovations, Inc. (SI) has an Altman Z-Score of 7.73, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Shoulder Innovations, Inc. (SI) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Shoulder Innovations, Inc. (SI) reported a net loss of $40.4M while operations used $28.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Shoulder Innovations, Inc. (SI) reported an operating loss of $26.3M against $70K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Shoulder Innovations, Inc. (SI) scores 56 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.